• Canadian Evidence-based recommendations for the use of Methotrexate (MTX) in daily clinical practice in rheumatic disorders are discussed in this presentation. Read more
  • Laboratory and non-laboratory investigations / evaluations can be helpful in confirming the diagnosis of gout. The presentation gives a brief overview of joint examinations, clinical, radiographic... Read more
  • This presentation on leflunomide gives a brief overview of rheumatic arthritis along with the available treatment modalities with emphasis on the safety and efficacy data of leflunomide. Read more
  • Ciploric contains allopurinol, 100 and 300 mg, which is a xanthine oxidase inhibitor, indicated in the treatment of primary and secondary hyperuricemia. The efficacy and safety of allopurinol in gout... Read more
  • The majority of patients with a confirmed diagnosis of RA use nonbiologic DMARDs and the rate of biologic DMARD use is rising rapidly. This presentation summarizes the ACR 2008 recommendations for... Read more
  • This presentation discusses the etiology, pathophysiology, clinical features, diagnosis and principles of management in RA along with some case studies. Read more
  • The principles in management of RA, Clinical Factors necessary for Therapeutic Decision-Making, Instruments used to Measure RA Disease Activity along with the therapeutic approach for RA patients... Read more
  • This presentation gives an overview of the available DMARDs and Biologics along with the special considerations to be taken into account when administering conventional (synthetic) or biologic DMARDs... Read more
  • This set of slides describes the classification of anti-arrhythmics and details the pharmacology of sotalol. A major part of this slide set discusses the clinical efficacy of sotalol in treating... Read more
  • Calcinase is salmon calcitonin nasal spray approved for the management of postmenopausal osteoporosis. In this presentation the mode of action along with the pharmacokinetics of the nasal spray are... Read more
  • Risedronate 150 is once monthly bisphosphonate approved for the prevention and treatment of osteoporosis. This presentation discusses the safety and efficacy of risedronate along with the dosage and... Read more
  • A brief overview of osteoporosis in terms of the epidemiology, morbidity and mortality associated with osteoporosis and both pharmacological and non-pharmacological intervention in osteoporosis has... Read more
  • In this presentation, Osteoporosis, the silent killer has been discussed with reference to the epidemiology, the risk factors both modifiable and non modifiable, the mortality and morbidity... Read more
  • It is estimated that up to 400 million people are chronically infected with the hepatitis B virus (HBV) worldwide. This slide set elaborates on important aspects of Hepatitis B with an overview on... Read more
  • This slide set presentation lays focus on the basics of ARMD, different forms of ARMD, signs & symptoms with various diagnostic tests available for detecting ARMD. It also describes the AREDS... Read more